Awards and Appointments General Research
23 January 2023
Cancer Research UK and the National Institute for Health and Care Research are investing over £3 million across the next five years into The University of Oxford’s Experimental Cancer Medicine Centre (ECMC). The investment will enable Oxford to expand its portfolio of precision prevention and early detection cancer trials.
Oxford is part of a network of 17 ECMCs across the UK which work in conjunction with local NHS facilities to deliver clinical trials of promising new treatments.
The new funding will allow Oxford to continue to explore novel, experimental treatments - including immunotherapies - for a wide variety of cancers, as well as trial interventions and improving existing therapies.
